229 related articles for article (PubMed ID: 26212119)
1. Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.
Benvenuti F; Gatto M; Larosa M; Iaccarino L; Punzi L; Doria A
Expert Opin Drug Saf; 2015; 14(9):1373-85. PubMed ID: 26212119
[TBL] [Abstract][Full Text] [Related]
2. Premature coronary heart disease in SLE: can we prevent progression?
Iaccarino L; Bettio S; Zen M; Nalotto L; Gatto M; Ramonda R; Punzi L; Doria A
Lupus; 2013 Oct; 22(12):1232-42. PubMed ID: 24097995
[TBL] [Abstract][Full Text] [Related]
3. [Atherosclerosis in systemic lupus erythematosus].
Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
[TBL] [Abstract][Full Text] [Related]
4. [High cardiovascular complications in systemic lupus erythematosus: physiopathology and risk management].
Boffa JJ; Rougier JP; Noël N; Ronco P
Nephrol Ther; 2009 Dec; 5(7):595-602. PubMed ID: 19733524
[TBL] [Abstract][Full Text] [Related]
5. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.
Gustafsson JT; Svenungsson E
Autoimmunity; 2014 Mar; 47(2):67-76. PubMed ID: 24228980
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus.
Oliveira CB; Kaplan MJ
Semin Immunopathol; 2022 May; 44(3):309-324. PubMed ID: 35355124
[TBL] [Abstract][Full Text] [Related]
7. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies.
Turano L
J Cardiovasc Nurs; 2013; 28(1):48-53. PubMed ID: 22210142
[TBL] [Abstract][Full Text] [Related]
8. [Assessing the cardiovascular risk in patients with systemic lupus erythematosus].
Arnaud L; Mathian A; Bruckert E; Amoura Z
Rev Med Interne; 2014 Nov; 35(11):723-9. PubMed ID: 25234464
[TBL] [Abstract][Full Text] [Related]
9. Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.
Fasano S; Margiotta DP; Navarini L; Pierro L; Pantano I; Riccardi A; Afeltra A; Valentini G
Lupus; 2017 Dec; 26(14):1463-1472. PubMed ID: 28786768
[TBL] [Abstract][Full Text] [Related]
10. Premature vascular damage in systemic lupus erythematosus.
Kaplan MJ
Autoimmunity; 2009 Nov; 42(7):580-6. PubMed ID: 19657770
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities.
Mauro D; Nerviani A
Rev Recent Clin Trials; 2018; 13(3):192-198. PubMed ID: 29542419
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease in systemic lupus erythematosus: an update.
Liu Y; Kaplan MJ
Curr Opin Rheumatol; 2018 Sep; 30(5):441-448. PubMed ID: 29870498
[TBL] [Abstract][Full Text] [Related]
13. Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge.
Bultink IE
Arthritis Res Ther; 2010; 12(1):107. PubMed ID: 20236499
[TBL] [Abstract][Full Text] [Related]
14. SLE and metabolic syndrome.
Parker B; Bruce I
Lupus; 2013 Oct; 22(12):1259-66. PubMed ID: 24097998
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular events in systemic lupus erythematosus and rheumatoid arthritis : emerging concepts, early diagnosis and management.
Chogle AR; Chakravarty A
J Assoc Physicians India; 2007 Jan; 55():32-40. PubMed ID: 17444342
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus and cardiovascular disease.
Frostegård J
Lupus; 2008 May; 17(5):364-7. PubMed ID: 18490408
[TBL] [Abstract][Full Text] [Related]
17. Management of cardiovascular risk in systemic lupus erythematosus: a systematic review.
Andrades C; Fuego C; Manrique-Arija S; Fernández-Nebro A
Lupus; 2017 Nov; 26(13):1407-1419. PubMed ID: 28457197
[TBL] [Abstract][Full Text] [Related]
18. [Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion].
Arnaud L; Mathian A; Adoue D; Bader-Meunier B; Baudouin V; Belizna C; Bonnotte B; Boumedine F; Chaib A; Chauchard M; Chiche L; Daugas E; Ghali A; Gobert P; Gondran G; Guettrot-Imbert G; Hachulla E; Hamidou M; Haroche J; Hervier B; Hummel A; Jourde-Chiche N; Korganow AS; Kwon T; Le Guern V; Le Quellec A; Limal N; Magy-Bertrand N; Marianetti-Guingel P; Martin T; Martin Silva N; Meyer O; Miyara M; Morell-Dubois S; Ninet J; Papo T; Pennaforte JL; Polomat K; Pourrat J; Queyrel V; Raymond I; Remy P; Sacre K; Schmidt J; Sibilia J; Viallard JF; Viau Brabant A; Wahl D; Bruckert E; Amoura Z;
Rev Med Interne; 2015 Jun; 36(6):372-80. PubMed ID: 25455954
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular benefits of habitual exercise in systemic lupus erythematosus: a review.
Barnes JN; Tanaka H
Phys Sportsmed; 2012 Sep; 40(3):43-8. PubMed ID: 23528620
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approaches.
Lopez-Pedrera C; Aguirre-Zamorano MÁ; Pérez-Sánchez C
Med Clin (Barc); 2017 Aug; 149(4):160-169. PubMed ID: 28619369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
